As of
SEC filer
AtaiBeckley Inc.
Classified by the SEC under Pharmaceutical Preparations · incorporated in Delaware · on EDGAR since 2025 · based in NEW YORK, NY.
Business address C/O ATAI LIFE SCIENCES US, INC., C/O INDUSTRIOUS NYC, 250 WEST 34TH ST., NEW YORK, NY, 10119
Company record
What SEC holds on AtaiBeckley Inc.
- CIK
- 2081043
- EIN
- Not disclosed in SEC filings
- SIC code
- 2834 — Pharmaceutical Preparations
- Entity type
- operating
- Filer status
- <br>Emerging growth company
- Incorporated in
- Delaware
- Fiscal year ends
- 31 December
- Business address
- C/O ATAI LIFE SCIENCES US, INC., C/O INDUSTRIOUS NYC, 250 WEST 34TH ST., NEW YORK, NY, 10119
Name history
Previously filed as
Companies rename, and their older filings stay under the old name. These are the names this CIK has filed under, as recorded by the SEC.
- atai Life Sciences Luxembourg S.A. 2025–2025
Corporate structure
Significant subsidiaries, as filed
From Exhibit 21 of this company’s most recent annual report. The SEC requires only significant subsidiaries to be listed, so this is not a complete corporate family — it is exactly what AtaiBeckley Inc. filed.
| Subsidiary | Jurisdiction of incorporation |
|---|---|
| atai Life Sciences US, Inc. | Delaware |
| atai Life Sciences GmbH | Germany |
| atai Life Sciences UK Ltd | England and Wales |
| Beckley Psytech Limited | England |
| atai Therapeutics, Inc. | Delaware |
| atai Therapeutics Holdings, Inc. | Delaware |
| EmpathBio, Inc. | Delaware |
| GABA Therapeutics, Inc. | Delaware |
| Nualtis Corp. | Canada |
| Perception Neuroscience Holdings, Inc. | Delaware |
| Recognify Holdco US, Inc. | Delaware |
Source: Exhibit 21, as filed with the SEC · accession 0001193125-26-096926
Reported financials
As filed with the SEC
Annual figures from this company’s own 10-K filings, tagged in XBRL. Restatements are reflected — where a year was refiled, the most recent value is shown.
Revenue
$4.1M
Net income
-$660M
Total assets
$293M
Shareholders' equity
$222M
Revenue by fiscal year
From 10-K filings, in US dollars.
View as table
| Period | Amount |
|---|---|
| 2024 | $308,000 |
| 2025 | $4,089,000 |
Net income by fiscal year
From 10-K filings, in US dollars. Bars below the line are loss years.
View as table
| Period | Amount |
|---|---|
| 2024 | -$149,269,000 |
| 2025 | -$660,047,000 |
Legal proceedings
As disclosed in the annual report
Item 3 of AtaiBeckley Inc.’s Form 10-K for fiscal 2025, filed 2026-03-06. This is the company’s own statement about its material legal proceedings — not a court record, and not a search of any docket.
The company answered Item 3 by pointing elsewhere in the same filing, which SEC rules permit (17 CFR 229.103(a)). Its full wording:
We are, from time to time, party to various claims and legal proceedings arising in the ordinary course of our business. Given that such proceedings are subject to uncertainty, there can be no assurance that such legal proceedings, either individually or in the aggregate, will not have a material adverse effect on our business, results of operations, financial condition or cash flows. See Note 20, Commitments and Contingencies , to our audited consolidated financial statements for additional information.
Quoted from the filing as submitted to the SEC. Read Item 3 in the 10-K itself ↗
Filing activity
What AtaiBeckley Inc. files
Form types across the 98 filings in SEC EDGAR’s current filing index for this company, 2025-08-13 to 2026-09-21.
| Form type | Filings | Share |
|---|---|---|
| 4 | 37 | |
| 8-K | 13 | |
| DEFA14A | 11 | |
| 144 | 5 | |
| S-8 POS | 4 | |
| SCHEDULE 13D/A | 3 | |
| 10-Q | 2 | |
| 424B3 | 2 | |
| 20 other form types | 21 |
Filing history
The 25 most recent filings
Of 98 in EDGAR’s current filing index for this company. Every filing, including older ones, is in the SEC’s own index ↗ .
| Form | Filed | Period | On EDGAR |
|---|---|---|---|
| 15-12G | 2026-09-21 | — | View filing ↗ |
| S-8 POS | 2026-09-17 | — | View filing ↗ |
| S-8 POS | 2026-09-16 | — | View filing ↗ |
| S-8 POS | 2026-09-16 | — | View filing ↗ |
| SCHEDULE 13D/A | 2026-09-14 | — | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| 4 | 2026-09-11 | 2026-09-11 | View filing ↗ |
| POS AM | 2026-09-11 | — | View filing ↗ |
| 25-NSE | 2026-09-11 | — | View filing ↗ |
| POS AM | 2026-09-11 | — | View filing ↗ |
| POSASR | 2026-09-11 | — | View filing ↗ |
| 8-K | 2026-09-11 | 2026-09-11 | View filing ↗ |
Identity, filing history and financials were retrieved live from SEC EDGAR on . The SEC is the source of record; verify anything you rely on against the filing linked above.
Continue searching
CorpFacts is an independent reference site. It is not affiliated with the IRS, the SEC, any state Secretary of State, or any other government agency, and it is not a filing service — we never file anything on your behalf and never charge for a federal form the IRS issues free. Records here summarize official public sources; confirm anything you rely on at the source. Nothing on this site is legal, tax or financial advice.